(Q54572569)

1 June 2018

title

Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. (English)

1 reference

1 June 2018

0 references

1 reference

11

1 reference

1 June 2018

Sylvie Giuriato

16

1 reference

1 June 2018

author name string

E Dejean

1

1 reference

1 June 2018

M H Renalier

2

1 reference

1 June 2018

M Foisseau

3

1 reference

1 June 2018

X Agirre

4

1 reference

1 June 2018

N Joseph

5

1 reference

1 June 2018

G R de Paiva

6

1 reference

1 June 2018

T Al Saati

7

1 reference

1 June 2018

J Soulier

8

1 reference

1 June 2018

C Desjobert

9

1 reference

1 June 2018

L Lamant

10

1 reference

1 June 2018

D W Felsher

12

1 reference

1 June 2018

J Cavaillé

13

1 reference

1 June 2018

H Prats

14

1 reference

1 June 2018

G Delsol

15

1 reference

1 June 2018

F Meggetto

17

1 reference

1 June 2018

publication date

22 July 2011

1 reference

1 June 2018

published in

Leukemia

1 reference

1 June 2018

volume

25

1 reference

1 June 2018

issue

12

1 reference

1 June 2018

page(s)

1882-1890

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1038/leu.2011.168

exact match

0 references

cites work

Angiogenesis in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Angiogenesis in lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Vascular endothelial growth factor (VEGF) signaling in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

miRNAs, cancer, and stem cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Epigenetic activation of tumor suppressor microRNAs in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Oncogenic kinase NPM/ALK induces expression of HIF1α mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Anaplastic lymphoma kinase: signalling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

The VEGF IRESes are differentially susceptible to translation inhibition by miR-16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Pathobiology of anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: a Children's Cancer and Leukaemia Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Crizotinib in anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Emergence and prevention of resistance against small molecule inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Past, present and future of targeted therapy in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Clinical trials with anti-angiogenic agents in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

microRNA-122 stimulates translation of hepatitis C virus RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

Regulation of hepatitis C virus by microRNA-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

The widespread regulation of microRNA biogenesis, function and decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

inferred from DOI database lookup

7 January 2021

based on heuristic

Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children - a report from the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

inferred from DOI database lookup

7 January 2021

based on heuristic

Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.168

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2011.168

1 reference

1 June 2018

PubMed ID

21778999

1 reference

1 June 2018